NEWS & ARTiCLES

« View all News & Articles

Perimenopause, Vaginal Dryness, and How an O-Shot Fits a Hormone Plan

Key Takeaways

  • Vaginal dryness during perimenopause is usually driven by declining and fluctuating estrogen, which thins tissue and reduces natural lubrication over time.
  • Systemic hormone therapy addresses the underlying hormonal picture, while localized treatments target the tissue itself, and the two approaches are often considered together.
  • The O-Shot® uses a patient’s own platelet rich plasma, drawn from a small blood sample and prepared in-office, to support the vaginal and clitoral tissue.
  • Comprehensive bloodwork gives us the hormonal and nutritional context needed before recommending any combination of treatments.
  • Results vary between individuals, and no single treatment resolves every symptom associated with the perimenopausal transition.

Many ladies come to our Frederick clinic telling us the same story in somewhat different terms. Intimacy is awkward. Lubrication, which was never a problem, seems to be missing today. Sleep is shattered, energy has tanked, and the calendar has become erratic. These changes tend to happen concurrently because they have a shared root in the changing hormonal milieu of perimenopause, which can begin years before periods stop altogether. We look at the whole hormonal picture before we make any recommendations, because if you focus on just one symptom, the satisfaction is often limited. That larger context matters very much for women thinking about an O-Shot in Frederick.

As a medical and aesthetics practice led by Dr. Jeanne O’Connell, we approach sexual wellness the same way we tackle hormone optimization, nutrition treatment, and skin health — testing first, customizing second. Vaginal dryness is a medical problem that can have very severe consequences for comfort, confidence and relationships. What it needs is a thought-out plan, not a single injection or a single prescription provided in isolation.

Hormonal Shifts Behind Vaginal Dryness in Perimenopause

Estrogen does a great deal of quiet work in the genitourinary tract. It supports the thickness and elasticity of the vaginal wall, maintains blood flow to the surrounding tissue, and helps sustain the glycogen levels that feed a healthy vaginal microbiome. As estrogen production becomes erratic and then declines through perimenopause, that supportive environment changes. Tissue can become thinner and less elastic, natural lubrication may decrease, and the pH balance can shift in ways that leave some women more prone to irritation.

The timeline is never neat. The perimenopause can last several years. Hormone levels may fluctuate from high to low in a single month. This variability is why symptoms can come and go before they settle into a consistent pattern. During this time, both progesterone (progesterone) and testosterone (testosterone) decrease. Testosterone in particular is responsible for libido in women and the arousal response. This point is often overlooked when discussions are focused only on estrogen.

Dryness is not a solitary condition. Women at this stage report many concerns, including:

  • Discomfort or pain during intercourse
  • Orgasm is difficult or impossible to achieve if you have reduced sensitivity
  • Urinary urgency and leakage after laughing, coughing or exercising
  • Itching that doesn’t go away with moisturizers purchased over the counter

Recognizing dryness as part of a systemic transition rather than a standalone problem shapes how we build a treatment plan. It also explains why we begin with comprehensive blood panel testing. Reviewing hormone levels, thyroid function, and nutrient status helps us distinguish what is hormonally driven from what may have another cause entirely.

Platelet Rich Plasma and Systemic Hormone Support Working Together

Bio-identical Hormone Replacement Therapy addresses the hormonal environment from the inside. When hormone levels are optimized under physician supervision, many women notice improvement across sleep, mood, energy, and tissue comfort, because the same hormones influence all of those systems. Hormone therapy is not appropriate for everyone, and candidacy depends on personal and family medical history, current health status, and the results of testing.

Local treatment is functioning on another level. The O-Shot® is a non-surgical therapy that employs a woman’s own platelet-rich plasma (PRP) that is drawn from the arm in a simple blood draw. The sample is spun in a centrifuge to separate out platelets and growth factors, a numbing lotion is administered, and a very small needle is used to insert the PRP near the clitoris and upper vaginal area. The in-office procedure takes around twenty minutes, and most women have little or no discomfort. There is no healing period as such.

The premise of PRP is that platelets contain growth factors, which have been researched for their ability to promote localized tissue repair and blood flow. Some women observe improvement very fast after therapy, but the fuller response tends to develop over around three months as tissue remodeling develops. Reported effects included enhanced lubrication, increased sensitivity, less discomfort with intercourse, and reduction in stress urinary incontinence. Individual response may vary, and PRP is not a substitute for medical assessment of urinary or gynecologic complaints that may have another cause.

The two approaches are complementary rather than competing. Hormone therapy influences the environment; PRP acts on the tissue directly. For women whose dryness persists even after their hormone levels have been optimized, adding an O-Shot in Frederick to an existing plan is a reasonable next conversation. For women who cannot or prefer not to pursue systemic hormone therapy, a localized option may still be worth discussing. We also offer InMode FormaV, VTone, and Morpheus8V, and depending on the presenting symptoms, one of those energy-based treatments may be the better fit or a useful complement.

Sequencing Treatment Around Testing and Physician Judgment

Order matters. Starting with a blood panel gives us objective information rather than assumptions, and it occasionally reveals contributors unrelated to estrogen, such as thyroid dysfunction or iron deficiency. Before any PRP procedure, we also review medication use, particularly anticoagulants, along with platelet status, active infection, and relevant medical history, since these factors affect both candidacy and how PRP is prepared and administered.

The physician’s supervision is not just a formality. PRP involves drawing blood and preparing it properly before injecting it into anatomically sensitive areas. This combination is best used in a medical environment with a doctor who can assess the patient as a whole, and not just the symptoms. Dr. O’Connell’s experience in integrative and regenerative medicine helps him make these decisions, such as when it’s best to refer the patient to a gynecologist.

The evidence is important to clarify. The research into PRP and female sexual function has been developing with promising early results but only limited large-scale studies to date. The FDA has cleared PRP preparation systems for specific uses. This particular application, however, is not FDA-approved as a treatment of sexual dysfunction. We are transparent about this because we believe that informed patients will make better decisions.

Treatment Considerations at a Glance

Concern Primary Approach Supporting Consideration
Systemic hormonal decline Bio-identical Hormone Replacement Therapy Requires bloodwork and ongoing physician monitoring
Localized tissue quality and lubrication O-Shot® platelet rich plasma Uses the patient’s own blood; response develops over about three months
Stress urinary incontinence O-Shot® or InMode VTone Evaluation needed to rule out other urologic causes
Laxity and tissue tone InMode FormaV or Morpheus8V Typically delivered as a treatment series
Fatigue, sleep, and nutrient status Comprehensive blood panel testing May reveal contributors unrelated to estrogen
Overall vitality support IV therapy and vitamin boosters Adjunctive, not a replacement for hormone evaluation

Perimenopause is a transition, not a diagnosis to be endured quietly. Vaginal dryness and the changes that accompany it respond to thoughtful evaluation, and the women who see the most satisfying outcomes tend to be those who treat the hormonal picture and the local tissue as connected rather than separate. That may mean hormone optimization on its own, a localized procedure on its own, or a combination built around what testing actually shows.

If discomfort, dryness, or changes in sensation have started to affect daily life, a consultation is the place to sort out which pieces apply to you. We can review your history, order the appropriate panels, and discuss whether an O-Shot in Frederick belongs in your plan alongside the other options available at our practice.